Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Urban

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Diagnostic Microbiology and Infectious Disease|April 21, 2009
Tricuspid valve endocarditis caused by Haemophilus parainfluenzae: a case report and review of the literatureNnamdi Nwaohiri, Carl Urban, Jason Gluck, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2013
Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICsMao Hagihara, Jared L Crandon, Carl Urban, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2004
In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumanniiJimmy Yoon, Carl Urban, Christian Terzian, et al.
Antimicrobial Agents and Chemotherapy|November 3, 2010
Polymyxin-resistant clinical isolates of Escherichia coliCarl Urban, Hemavarna Tiruvury, Noriel Mariano, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York CityMarie Abdallah, Olawole Olafisoye, Christopher Cortes, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2015
Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York CityAmabel Lapuebla, Marie Abdallah, Olawole Olafisoye, et al.
Idcases|February 7, 2023
Omadacycline for the treatment of <i>Mycobacterium abscessus</i> infections: Case series and review of the literatureAyesha Siddiqa, Shanza Khan, George D Rodriguez, et al.
American Journal of Infection Control|March 31, 2015
Reduction in the prevalence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in New York CityMarie Abdallah, Olawole Olafisoye, Christopher Cortes, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2015
Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York CityAmabel Lapuebla, Marie Abdallah, Olawole Olafisoye, et al.
Journal of Clinical Microbiology|October 8, 2010
Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinityDavid Landman, Carl Urban, Martin Bäcker, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Diagnostic Microbiology and Infectious Disease|April 21, 2009
Tricuspid valve endocarditis caused by Haemophilus parainfluenzae: a case report and review of the literatureNnamdi Nwaohiri, Carl Urban, Jason Gluck, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2013
Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICsMao Hagihara, Jared L Crandon, Carl Urban, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2004
In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumanniiJimmy Yoon, Carl Urban, Christian Terzian, et al.
Antimicrobial Agents and Chemotherapy|November 3, 2010
Polymyxin-resistant clinical isolates of Escherichia coliCarl Urban, Hemavarna Tiruvury, Noriel Mariano, et al.
Antimicrobial Agents and Chemotherapy|December 24, 2014
Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York CityMarie Abdallah, Olawole Olafisoye, Christopher Cortes, et al.
Antimicrobial Agents and Chemotherapy|June 3, 2015
Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York CityAmabel Lapuebla, Marie Abdallah, Olawole Olafisoye, et al.
Idcases|February 7, 2023
Omadacycline for the treatment of <i>Mycobacterium abscessus</i> infections: Case series and review of the literatureAyesha Siddiqa, Shanza Khan, George D Rodriguez, et al.
American Journal of Infection Control|March 31, 2015
Reduction in the prevalence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in New York CityMarie Abdallah, Olawole Olafisoye, Christopher Cortes, et al.
Antimicrobial Agents and Chemotherapy|May 28, 2015
Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York CityAmabel Lapuebla, Marie Abdallah, Olawole Olafisoye, et al.
Journal of Clinical Microbiology|October 8, 2010
Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinityDavid Landman, Carl Urban, Martin Bäcker, et al.
Pageof 5